These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17298881)

  • 1. ED-71, a new active vitamin D3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects.
    Matsumoto T; Kubodera N
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):584-6. PubMed ID: 17298881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial.
    Matsumoto T; Miki T; Hagino H; Sugimoto T; Okamoto S; Hirota T; Tanigawara Y; Hayashi Y; Fukunaga M; Shiraki M; Nakamura T
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5031-6. PubMed ID: 15972580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the effect of eldecalcitol and serum 25(OH)D level.
    Takano T; Kondo S; Saito H; Matsumoto T;
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():124-7. PubMed ID: 24240066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eldecalcitol increases bone mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation.
    Jiang Y; Tang H; Ma X; Cheng Q; Lin H; Jin X; Zhang Z; Yu W; He S; Kobayashi T; Uehara S; Matsumoto T; Xia W
    J Bone Miner Metab; 2019 Nov; 37(6):1036-1047. PubMed ID: 31087185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic agents for disorders of bone and calcium metabolism: ED-71].
    Tsuji N; Takahashi F
    Clin Calcium; 2007 Jan; 17(1):72-9. PubMed ID: 17211096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Eldecalcitol (ED-71)].
    Endo I; Matsumoto T
    Clin Calcium; 2011 Jan; 21(1):53-8. PubMed ID: 21187594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
    Mawatari T; Muraoka R; Iwamoto Y
    Osteoporos Int; 2017 Apr; 28(4):1279-1286. PubMed ID: 27900428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients.
    Kubodera N; Tsuji N; Uchiyama Y; Endo K
    J Cell Biochem; 2003 Feb; 88(2):286-9. PubMed ID: 12520528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
    Klassen KM; Kimlin MG; Fairley CK; Emery S; Anderson PH; Ebeling PR;
    Osteoporos Int; 2016 May; 27(5):1737-45. PubMed ID: 26659069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis.
    Roux C; Binkley N; Boonen S; Kiel DP; Ralston SH; Reginster JY; Pong A; Rosenberg E; Santora A;
    Calcif Tissue Int; 2014 Feb; 94(2):153-7. PubMed ID: 23912950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Serum 25(OH)D
    Nakamura Y; Uchiyama S; Kamimura M; Ikegami S; Komatsu M; Kato H
    Tohoku J Exp Med; 2017 Jul; 242(3):241-246. PubMed ID: 28740036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic women.
    Ishijima M; Sakamoto Y; Yamanaka M; Tokita A; Kitahara K; Kaneko H; Kurosawa H
    Calcif Tissue Int; 2009 Nov; 85(5):398-404. PubMed ID: 19795092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.
    Sakai A; Ito M; Tomomitsu T; Tsurukami H; Ikeda S; Fukuda F; Mizunuma H; Inoue T; Saito H; Nakamura T;
    Osteoporos Int; 2015 Mar; 26(3):1193-202. PubMed ID: 25592133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of denosumab co-administered with vitamin D and Ca by baseline vitamin D status.
    Sugimoto T; Matsumoto T; Hosoi T; Shiraki M; Kobayashi M; Okubo N; Takami H; Nakamura T
    J Bone Miner Metab; 2020 Nov; 38(6):848-858. PubMed ID: 32671481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term 1,25(OH)2 vitamin D therapy increases bone mineral density in osteopenic women. Comparison with the effect of plain vitamin D.
    Zofkova I; Hill M
    Aging Clin Exp Res; 2007 Dec; 19(6):472-7. PubMed ID: 18172369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A; Constancio L; Fogelman I; Hampson G
    BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin A intake, serum vitamin D and bone mineral density: analysis of the Korea National Health and Nutrition Examination Survey (KNHANES, 2008-2011).
    Joo NS; Yang SW; Song BC; Yeum KJ
    Nutrients; 2015 Mar; 7(3):1716-27. PubMed ID: 25763530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.